Lilly bags Retevmo FDA approval for RET-driven lung and thyroid cancers

Retevmo FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Retevmo (selpercatinib, 40mg and 80mg capsules) for the treatment of adults with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC). Retevmo has also been approved by the FDA for More...

by pharmanewsdaily | Published 3 weeks ago
By pharmanewsdaily On Thursday, May 7th, 2020
0 Comments

Bonne Santé Natural Immunology nutraceutical products launched

US nutraceutical company Bonne Santé Group has launched Bonne Santé Natural Immunology, a new range of nutraceutical products designed to boost the immune system functions. Bonne Santé Natural Immunology is made More...

By pharmanewsdaily On Thursday, May 7th, 2020
0 Comments

AbbVie acquisition of Allergan gets antitrust clearance from US FTC

AbbVie acquisition of Allergan update : US biopharma company AbbVie has secured clearance from the US Federal Trade Commission (FTC) for its previously announced $63 billion acquisition of Botox developer Allergan. According More...

By pharmanewsdaily On Wednesday, May 6th, 2020
0 Comments

Alexion Pharmaceuticals to acquire Portola Pharmaceuticals for $1.4bn

Alexion acquisition of Portola : Alexion Pharmaceuticals has agreed to acquire Portola Pharmaceuticals, a commercial-stage biopharma company focused on life-threatening blood-related disorders, for $1.41 billion. Portola More...

By pharmanewsdaily On Tuesday, May 5th, 2020
0 Comments

Italy’s Menarini to acquire US biopharma company Stemline Therapeutics

Menarini acquisition of Stemline : Menarini Group, an Italian pharma and diagnostics company, has agreed to acquire US biopharma company Stemline Therapeutics in a deal worth up to $677 million. Stemline Therapeutics More...

By pharmanewsdaily On Monday, May 4th, 2020
0 Comments

FDA grants EUA for Gilead’s investigational COVID-19 drug remdesivir

Remdesivir EUA status : The US has officially pushed the use of remdesivir for treating the novel coronavirus with the Food and Drug Administration (FDA) granting emergency use authorization (EUA) to the investigational More...

By pharmanewsdaily On Monday, May 4th, 2020
0 Comments

BioMarin, DiNAQOR to develop gene therapies for rare genetic cardiomyopathies

BioMarin Pharmaceutical has signed a preclinical collaboration and license deal with Swiss gene therapy platform company DiNAQOR to develop novel gene therapies for the treatment of rare genetic cardiomyopathies. DiNAQOR More...

By pharmanewsdaily On Friday, May 1st, 2020
0 Comments

Eiger BioPharmaceuticals doses first patients with Lambda in COVID-19 trial

Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis delta virus drug candidate peginterferon lambda (Lambda) in outpatients at the Stanford University School of More...

By pharmanewsdaily On Friday, May 1st, 2020
0 Comments

Trio Pharmaceuticals, Aji Bio-Pharma to co-develop antibody drug conjugates

Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) have entered into a development collaboration agreement to assess AJICAP, a site-specific conjugation technology offered by the latter for More...

By pharmanewsdaily On Thursday, April 30th, 2020
0 Comments

Verndari begins preclinical testing of COVID-19 vaccine candidate

Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. The preclinical testing More...